The U.S. government will provide Merck and Johnson and Johnson with $100M so the companies can double the current output of J&J's COVID-19 vaccine.
This is an excerpt from the March 2, 2021 edition of Medically Necessary, a health care supply chain newsletter. Subscribe here.Good afternoon. Medically Necessary is a...
By Geoffrey Smith Investing.com -- The U.S. will have enough vaccines for all adults by May, while Texas is ending restrictions on business and lifting its mask mandate. ADP...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Sell | Sell |
| Technical Indicators | Sell | Sell | Strong Buy | Strong Sell | Strong Sell |
| Summary | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 26.77 | 27.67 | 26.40 | -0.52 | -1.91% | 2.19M | Toronto | |||
| 32.60 | 35.50 | 31.35 | -4.39 | -11.87% | 121.17K | TSXV | |||
| 139.58 | 140.01 | 129.03 | -23.58 | -14.45% | 562.63K | Toronto | |||
| 22.05 | 23.25 | 21.18 | -0.960 | -4.17% | 2.04M | Toronto | |||
| 2.98 | 3.00 | 2.54 | +0.690 | +30.13% | 17.50K | TSXV | |||
| 1.02 | 1.02 | 0.00 | +0.03 | +3.03% | 253.64K | CSE | |||
| 0.71 | 0.00 | 0.00 | -0.0850 | -10.69% | 3.06M | TSXV | |||
| 50.04 | 50.10 | 49.51 | +0.33 | +0.66% | 539.96K | Toronto | |||
| 2.40 | 2.74 | 2.33 | -0.3400 | -12.41% | 1.68M | TSXV | |||
| 20.30 | 21.91 | 19.60 | -0.93 | -4.38% | 659.47K | Toronto | |||
| 26.09 | 26.18 | 25.85 | +0.03 | +0.12% | 707.96K | Toronto | |||
| 3.94 | 3.97 | 3.93 | -0.01 | -0.25% | 47.13K | Toronto | |||
| 4.84 | 5.37 | 4.61 | -0.6000 | -11.03% | 2.08M | TSXV | |||
| 55.84 | 56.08 | 55.47 | +0.27 | +0.49% | 909.50K | Toronto | |||
| 0.57 | 0.00 | 0.00 | -0.23 | -28.75% | 1.10K | TSXV |
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.